Kliničke studije za Ekcem u državi Florida
9 studija za Ekcem traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
Službeni tekst studije (engleski)
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
- Clinical Site 110, Miami
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 65 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07453602Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Miami
- Novartis Investigative Site, St. Petersburg
U tijeku regrutacijaFaza 2
Od 18 do 100 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT06947993A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- Solutions Through Advanced Research, Jacksonville
U tijeku regrutacijaFaza 3
Od 6 do 11 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06807268A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Solutions Through Advanced Research, Jacksonville
U tijeku regrutacijaFaza 3
Od 2 do 11 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06807281A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Gsi Clinical Research, Margate
U tijeku regrutacijaFaza 2
Od 18 do 64 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07216027A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- AllerVie Clinical Research, Panama City
- GCP Research , Global Clinical Professionals, St. Petersburg
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- ABMED Clinical Research Corp., Cape Coral
- Skin Care Research, Hollywood
- Quality Care Clinical Research, Miami
- i još 4
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 28. kol 2026. · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 19, Ocala
- Inmagene Site 4, Tampa
U tijeku regrutacijaFaza 2
Od 18 do 74 godina · Oba spola · Ažurirano 12. kol 2026. · NCT07037901A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Revival Research, Doral
- Floridian Research Institute Llc, Miami
- Global Health Research Center, Inc., Miami Lakes
- i još 4
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 4. svi 2026. · NCT05995964Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.